Track the 메디포스트 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 메디포스트 has published 66 reports. The latest transaction was filed on 20 January 2026 (Purchase). Among the most active insiders: 스카이메디. The full history is free.
66
Insider Decl.
n/a
Thresholds
n/a
15 ops.
Buy Volume
n/a
40 ops.
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
메디포스트 es una empresa del sector de la salud y farmacéutico, que cotiza en el XKRX. Se centra en el desarrollo de terapias celulares y productos biofarmacéuticos.